Overview

Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas

Status:
Unknown status

Trial end date:
2017-04-01

Target enrollment:

Participant gender:

Summary

This prospective cohort, phase II, trial is studying induction chemotherapy combination, FOLFIRINOX regimen, consisted of oxaliplatin, irinotecan, leucovorin and fluorouracil (5-FU), for 4 cycles, followed by consolidation concurrent radiotherapy with capecitabine in non-progressed cases, in treating patients with locally advanced cancer pancreas.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Assiut University

Treatments:

Capecitabine
Fluorouracil
Folfirinox
Irinotecan
Oxaliplatin
Pancreatin
Pancrelipase